Please use this identifier to cite or link to this item: https://doi.org/10.1080/10508422.2016.1189333
Title: Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits
Authors: Melvyn Zhang
Roger Ho 
Issue Date: 10-Jun-2016
Publisher: Taylor & Francis
Citation: Melvyn Zhang, Roger Ho (2016-06-10). Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits. Ethics & Behavior 27 (8) : 681-699. ScholarBank@NUS Repository. https://doi.org/10.1080/10508422.2016.1189333
Source Title: Ethics & Behavior
URI: http://scholarbank.nus.edu.sg/handle/10635/141061
ISSN: 1050-8422
DOI: 10.1080/10508422.2016.1189333
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10.108010508422.2016.1189333.zip91.42 kBZIP

OPEN

NoneView/Download

Page view(s)

10
checked on Aug 9, 2018

Download(s)

7
checked on Aug 9, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.